Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors

Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I

(2014) Shajila Siricilla et al.   ANALYTICAL BIOCHEMISTRY

One-Pot Protection-Glycosylation Reactions for Synthesis of Lipid II Analogues

(2014) Katsuhiko Mitachi et al.   CHEMISTRY-A EUROPEAN JOURNAL

Improved Synthesis of Capuramycin and Its Analogues

(2013) Yong Wang et al.   CHEMISTRY-A EUROPEAN JOURNAL

Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan

(2013) J.-Y. Chien et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Inhibition of the First Step in Synthesis of the Mycobacterial Cell Wall Core, Catalyzed by the GlcNAc-1-phosphate Transferase WecA, by the Novel Caprazamycin Derivative CPZEN-45

(2013) Yoshimasa Ishizaki et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Screening mutant libraries of T7 RNA polymerase for candidates with increased acceptance of 2′-modified nucleotides

(2012) Vanessa Siegmund et al.   CHEMICAL COMMUNICATIONS

The Tuberculous Granuloma: An Unsuccessful Host Defence Mechanism Providing a Safety Shelter for the Bacteria?

(2012) Mayra Silva Miranda et al.   Clinical & Developmental Immunology

Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment

(2012) Jean Engohang-Ndong   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis

(2012) Joy Debnath et al.   JOURNAL OF MEDICINAL CHEMISTRY

HIV-1/Mycobacterium tuberculosisCoinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?

(2011) Collin R. Diedrich et al.   INFECTION AND IMMUNITY

Simple Model for Testing Drugs against Nonreplicating Mycobacterium tuberculosis

(2010) C. Sala et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The chemical biology of new drugs in the development for tuberculosis

(2010) Clifton E Barry et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Chemical modification of capuramycins to enhance antibacterial activity

(2010) Elena Bogatcheva et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria

(2010) T. Dubuisson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activity of SQ641, a Capuramycin Analog, in a Murine Model of Tuberculosis

(2009) B. V. Nikonenko et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus

(2009) J. Meletiadis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synthetic Studies on Mycobacterium tuberculosis Specific Fluorescent Park’s Nucleotide Probe

(2009) Michio Kurosu et al.   HETEROCYCLES

Synthetic Studies towards the Identification of Novel Capuramycin Analogs with Mycobactericidal Activity

(2009) Michio Kurosu et al.   HETEROCYCLES

Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability

(2009) M. Gengenbacher et al.   MICROBIOLOGY-SGM

Concise Synthesis of Capuramycin

(2009) Michio Kurosu et al.   ORGANIC LETTERS

HIV-1 Replication Is Differentially Regulated by Distinct Clinical Strains of Mycobacterium tuberculosis

(2009) Shahin Ranjbar et al.   PLoS One

Bacterial Growth and Cell Division: a Mycobacterial Perspective

(2008) E. C. Hett et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS